Mieux comprendre la prise en charge de la pandémie due au SARS-CoV-2 : analyse épidémiologique, immunologique et vaccinale (notice n° 756841)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02146cam a2200241 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123100623.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Haas, Hervé |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Mieux comprendre la prise en charge de la pandémie due au SARS-CoV-2 : analyse épidémiologique, immunologique et vaccinale |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2021.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 23 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméLa pandémie mondiale de SARS-CoV-2 depuis sa révélation en décembre 2019 fait l’objet de publications dans le monde entier et surtout de communications dans les médias, y compris la presse dite grand public, utilisant un vocabulaire que la majorité de la population ne connait pas et qui n’est pas toujours compris dans le milieu médical. Ce lexique a pour objectif d’aider à mieux comprendre les critères d’évaluation d’une épidémie, l’immunité, le rôle de l’ACE2, les différents types de tests à notre disposition, ainsi que les différents types de vaccins, et ainsi de donner les clés pour appréhender de manière plus efficace les nombreuses communications écrites et orales. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The SARS-CoV-2 global pandemic since its revelation in December 2019 has been the subject of publications around the world and especially of communications in the media, including the so-called mainstream press, using a vocabulary that the majority of the population does not know, and which is not always understood in the medical community. This lexicon aims to help better understand criteria for evaluating an epidemic, immunity, role of ACE2, the different types of tests available, as well as the different types of vaccines, and thus giving the keys to more effectively apprehending the many written and oral communications. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | Sars-CoV-2 ; pandémie ; vaccin ; immunité ; test |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | immunity |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | test |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | COVID-19 |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vaccine |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | pandemia |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Médecine thérapeutique / Pédiatrie | 23 | 1 | 2021-01-01 | p. 6-15 | 1286-5494 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-medecine-therapeutique-pediatrie-2021-1-page-6?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-medecine-therapeutique-pediatrie-2021-1-page-6?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux